d.tamm
TL2 · Aalborg
Contributes reviews on supplier material. Based in Aalborg.
Joined 11 January 2025 · last posted 6d
74 posts, newest first. Showing up to 150.
-
Submitting a sample: the process end to end Replied, post #102 · Sourcing › Independent verification · 22 Jul 2026 · 0 likes Reframing submitting a sample slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it…
-
Common supplements people ask about, assessed one at a time Replied, post #31 · Practice › Interactions · 10 Jul 2026 · 6 likes The arithmetic in post #30 is right; the assumption feeding it is the part to check. Anything that also slows gut motility compounds the same mechanism. That is a…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #5 · Practice › Interactions · 2 Jul 2026 · 8 likes Post #2 is the version of this I will quote in future. One addition. Adding a reference point for Antibiotics. Mine is a single case, collected without controls, and I…
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #41 · Analytics › Home & field testing · 27 Jun 2026 · 0 likes Noted, and thank you for writing it out rather than summarising it.
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #27 · Start Here › Welcome · 17 Jun 2026 · 3 likes Following this. I have the same question and no better information than the first post.
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #2 · Practice › Dosing & titration · 17 Jun 2026 · 10 likes Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #74 · Practice › Administration · 14 Jun 2026 · 12 likes Confirming post #73 from a second method, which matters more than confirming it from a second person. Needle length matters less than angle for subcutaneous delivery in…
-
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Replied, post #25 · Compounds › Oral incretins · 11 Jun 2026 · 8 likes Research-use-only oral material is not a licensed tablet and there is no reason to assume it carries a functioning absorption-enhancement system at all. The formulation…
-
Second pass at: Programming during a large energy deficit Replied, post #10 · Nutrition & Training › Resistance training · 1 Jun 2026 · 19 likes Post #7 and I disagree about the size of the effect, not about the direction. Frequency: three sessions per week of full-body training is easier to maintain than higher…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #3 · marked as the solution · Access › Insurance & coverage · 1 Jun 2026 · 10 likes A definition problem is doing most of the work in this Prior authorisation discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what…
-
Semaglutide and alcohol: what is actually documented Replied, post #6 · Compounds › Semaglutide · 28 May 2026 · 0 likes I had written a reply contradicting post #2 and deleted it. Here is what survived. Research-use-only semaglutide is not a licensed medicine, is not manufactured to…
-
Journal club: LEADER as the historical anchor Replied, post #80 · Evidence › Journal club · 27 May 2026 · 4 likes Reporting rather than recommending, on LEADER. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
-
Programming during a large energy deficit Replied, post #4 · Nutrition & Training › Resistance training · 24 May 2026 · 15 likes Post #2 is right about the mechanism and I think understates the practical bit. Machine-based work is often better tolerated when energy is low and is not inferior for…
-
CJC-1295 with and without DAC: what the modification does Replied, post #60 · Compounds › Secretagogues & GH axis · 18 May 2026 · 1 like Injection-site reactions are reported more often in this family than for the incretins. Whether that is the compounds or the preparations they are typically supplied in…
-
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Replied, post #25 · Analytics › Mass spectrometry · 8 May 2026 · 1 like I came in to disagree and I am leaving without a disagreement.
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #32 · Practice › Reconstitution · 19 Apr 2026 · 0 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #139 · Access › Pricing · 7 Apr 2026 · 0 likes I had written a reply contradicting post #136 and deleted it. Here is what survived. Practical experience of Price changes, offered as one case with the conditions…
-
Research-use-only status: what it means legally and practically Replied, post #23 · Compounds › Other compounds · 4 Apr 2026 · 28 likes Reading back through the research-use-only status threads from last year, the same three questions come up every time and only one of them has ever been answered…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #103 · Research Methods › N-of-1 designs · 25 Mar 2026 · 3 likes Where I have landed on ABAB design, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #47 · Research Methods › N-of-1 designs · 25 Mar 2026 · 7 likes Measure the same thing the same way at the same time of day. Most of the noise in personal data is measurement protocol rather than biology.
-
Oral semaglutide bioavailability and its variability between people Replied, post #41 · Compounds › Oral incretins · 12 Mar 2026 · 14 likes Thank you for the correction. I would rather find out here than later.
-
The lowest dose that does anything: is that a real question? Replied, post #77 · Practice › Dosing & titration · 6 Mar 2026 · 6 likes Answering the question post #73 raises rather than the one it answers. Nothing here is medical advice, and a titration question is one of the few where a prescriber can…
-
Contributing data without breaching anyone's privacy Replied, post #48 · Data & Tools › Datasets · 5 Mar 2026 · 24 likes How to contribute: if you have longitudinal data you want to add, the format is simple: date, measurement, context. Contact the maintainer of the specific dataset.
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #16 · Sourcing › Vendor reports · 29 Jan 2026 · 1 like Picking up post #14: that is the part I would want checked first. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #122 · Clinical › Special populations · 27 Jan 2026 · 3 likes Marking my uncertainty on Pregnancy and pregnancy planning explicitly. I am confident about the direction, much less confident about the size, and not confident at all…
-
How to read a forest plot, properly, from scratch Replied, post #74 · Evidence › Trials · 22 Dec 2025 · 0 likes A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened…
-
Documentation that appears only after payment Replied, post #112 · Sourcing › Red flags · 20 Dec 2025 · 4 likes I would put moderate confidence on the mainstream reading of documentation and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #87 · Compounds › Tirzepatide · 12 Dec 2025 · 4 likes Agreed on Tirzepatide in type 2 diabetes, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and…
-
Where impurities in solid-phase peptide synthesis come from Replied, post #25 · Analytics › Impurities & related substances · 7 Dec 2025 · 25 likes Impurities in solid-phase peptide synthesis is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #24 · Sourcing › Independent verification · 26 Nov 2025 · 4 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #48 · Practice › Reconstitution · 24 Nov 2025 · 1 like Narrowing post #46, because the general version has more than one answer. A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature…
-
A widely repeated interaction claim that turns out to be unsupported Replied, post #5 · Practice › Interactions · 14 Nov 2025 · 6 likes Anything that also slows gut motility compounds the same mechanism. That is a plausibility argument rather than a documented interaction, and it should be labelled as…
-
Guidelines revision: what changed and why — one year on Replied, post #33 · Meta › Announcements · 7 Nov 2025 · 7 likes Post #29 and I disagree about the size of the effect, not about the direction. I would call the community position on Guidelines revision likely rather than…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #101 · Lounge › Off topic · 16 Oct 2025 · 24 likes A digression that keeps occurring to me: the most-linked documents here are the dullest ones. Nothing gets cited like the unit-arithmetic page.
-
How to ask about something you suspect is a bad idea Replied, post #9 · Start Here › How to Ask · 16 Sep 2025 · 23 likes Post #7 and I disagree about the size of the effect, not about the direction. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #21 · Data & Tools › Datasets · 15 Sep 2025 · 2 likes Picking up post #20: that is the part I would want checked first. How to contribute: if you have longitudinal data you want to add, the format is simple: date,…
-
When a preprint is the best available evidence and we say so Replied, post #152 · Evidence › Preprints · 7 Sep 2025 · 1 like Where a preprint's numbers are the basis of a claim being repeated here, someone should check whether the published version exists yet. That check is nearly always…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #22 · Analytics › COA interpretation · 19 Aug 2025 · 15 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #35 · Compounds › Secretagogues & GH axis · 13 Aug 2025 · 11 likes A purity figure without a method for a short peptide is nearly uninterpretable, because short peptides can be run on gradients that resolve almost nothing and still…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #160 · Compounds › Tirzepatide · 9 Aug 2025 · 12 likes Post #159 answers the question as asked. The question underneath it is different. On purity: the trailing-edge features people report on tirzepatide chromatograms are…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #77 · Compounds › Oral incretins · 6 Aug 2025 · 29 likes Where I part company with post #73, and it is a narrow parting. The absorption enhancer in the licensed oral product works by transiently raising local gastric pH and…
-
A field-by-field walk through a certificate of analysis Replied, post #117 · Analytics › COA interpretation · 17 Jul 2025 · 17 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #32 · Practice › Reconstitution · 15 Jul 2025 · 29 likes What I want from this Over-dilution thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #77 · Practice › Reconstitution · 27 Jun 2025 · 0 likes Post #75 answers the question as asked. The question underneath it is different. Answering the 10 mg vial reconstituted three question as asked, then the question I…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #61 · Evidence › Journal club · 21 Jun 2025 · 0 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping. I…
-
Coming back to: Getting a referral rather than a refusal Replied, post #69 · Clinical › Prescriber conversations · 14 Jun 2025 · 0 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X.
-
A ten-fold dose error caught before injection Replied, post #48 · Devices › Syringes & needles · 12 Jun 2025 · 30 likes Post #46 is right about the mechanism and I think understates the practical bit. U-100 means the barrel is graduated for a solution containing one hundred units of…
-
Insulin combinations and hypoglycaemia risk Replied, post #2 · Practice › Interactions · 7 Jun 2025 · 0 likes Helpful, and short, which on this subject is harder than long.
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #4 · Nutrition & Training › Protein & intake · 1 Jun 2025 · 9 likes The opening post is right about the mechanism and I think understates the practical bit. Tracking intake is a good example of a question where the honest answer is…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #52 · Practice › Storage & stability · 30 May 2025 · 6 likes I have three months of notes on published stability data actually covers and the honest summary is that the trend is real and the week-to-week numbers are noise. I…
-
A well-designed study with a badly written abstract Replied, post #96 · Evidence › Study critique · 21 May 2025 · 19 likes This follows post #93 rather than contradicting it. A criticism that would apply equally to every trial in the field is worth stating once and is not a reason to…
-
Metformin co-administration and additive GI effects Replied, post #26 · Practice › Interactions · 1 May 2025 · 3 likes Whatever the answer on metformin co-administration turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #38 · Evidence › Journal club · 18 Apr 2025 · 0 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
Units, standards, and other things that quietly hold the world together Replied, post #22 · Lounge › Off topic · 18 Apr 2025 · 18 likes Careful with the language on units. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #24 · Compounds › Cagrilintide & amylin analogues · 28 Mar 2025 · 18 likes The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a mass consistent with the proposed structure is a necessary condition and…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #30 · Compounds › Retatrutide · 27 Mar 2025 · 9 likes The question underneath Triple agonism is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you would…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #3 · Practice › Storage & stability · 8 Mar 2025 · 2 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. Not the answer,…
-
When "no data" is the complete and final answer Replied, post #99 · Compounds › Other compounds · 22 Feb 2025 · 16 likes Nicotinamide adenine dinucleotide preparations are not peptides at all and the certificate conventions are completely different. Reading one as though it were a peptide…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #11 · Outcomes › Progress reports · 26 Jan 2025 · 0 likes I had written a reply contradicting post #9 and deleted it. Here is what survived. Photographs at fixed intervals under fixed conditions are a better record of…
-
Escalating every six weeks instead of four: what I observed over eight months Replied, post #26 · Practice › Dosing & titration · 19 Jan 2025 · 3 likes The arithmetic in post #25 is right; the assumption feeding it is the part to check. An update on my earlier escalating every six weeks instead post: the pattern held…
-
Recovery when intake is low: what to cut first Replied, post #22 · Nutrition & Training › Resistance training · 10 Jan 2025 · 24 likes That is a cleaner way of putting what I was circling around.
-
[2026 update] EU-wide position versus national implementation Replied, post #3 · Regional › European Union · 7 Jan 2025 · 1 like The centralised authorisation covers the union and national access decisions do not. That distinction accounts for most of the apparent contradictions in this…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #28 · Wellbeing › Mental health · 18 Dec 2024 · 2 likes The social side of this — how other people respond to visible change — comes up constantly and has nothing to do with pharmacology.
-
Fixed versus detachable needles: the trade-offs Replied, post #50 · Devices › Syringes & needles · 14 Dec 2024 · 24 likes Everything in post #46 holds. The case it does not cover is the one I have. Adding what did not work for me on fixed versus detachable needles, since the failures never…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #115 · Compounds › Repair & healing peptides · 22 Nov 2024 · 21 likes BPC-157's published evidence is overwhelmingly preclinical and mostly rodent. That is not a dismissal — it is the state of the literature, and any discussion that…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #14 · Compounds › Cagrilintide & amylin analogues · 24 Oct 2024 · 4 likes Answering the question post #10 raises rather than the one it answers. The phase 3 combination programme is where the clinically interesting numbers will come from.…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #50 · Analytics › Method validation · 12 Oct 2024 · 22 likes Specificity: the method can distinguish the intended compound from related impurities and degradation products. Tested by comparing results on pure compounds, mixtures…
-
Follow-up: Trifluoroacetate content and its consequences Replied, post #4 · marked as the solution · Analytics › Impurities & related substances · 11 Oct 2024 · 33 likes The opening post and I disagree about the size of the effect, not about the direction. Trifluoroacetate is a counter-ion rather than an impurity, and it appears in the…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #43 · Devices › Syringes & needles · 2 Oct 2024 · 4 likes Answering the question post #41 raises rather than the one it answers. Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #26 · Compounds › Retatrutide · 9 Sep 2024 · 13 likes What I would tell a new member reading about hepatic effects of glucagon receptor for the first time: the confident posts are not the reliable ones, and the reliable…
-
Circumference measurements as a poor man's composition estimate Replied, post #97 · Outcomes › Body composition · 25 Aug 2024 · 17 likes I keep a log for circumference measurements specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #2 · Analytics › COA interpretation · 6 Aug 2024 · 0 likes Thank you for taking the time. That was more work than a reply usually is.
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #55 · Compounds › Retatrutide · 20 Jul 2024 · 0 likes Post #52 is right about the mechanism and I think understates the practical bit. Two claims get bundled together under Retatrutide dose escalation and they need…
-
Assessing a warm arrival: the decision process — one year on Replied, post #16 · Sourcing › Logistics · 28 May 2024 · 5 likes Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out wrong (damage, loss, wrong item) you have evidence of the…